ALLHAT and AFFIRM

Because of the proliferation of clinical trials relevant to preventive cardiology, this new section of the journal is being initiated to review recently published findings from randomized clinical studies with the potential to significantly alter medical practice. Each issue of Preventive Cardiology will address one or more of these trials with commentary by Philip R. Liebson, MD, editor of the section. Dr. Liebson is Professor of Medicine and Preventive Medicine and Associate Director, Section of Cardiology, Rush Medical College, Rush-Presbyterian-St. Luke's Medical Center, Chicago, IL. He is a member of our founding Editorial Board with extensive experience and investigative activity in clinical cardiology and preventive cardiology. It is hoped that this series will promote discussion and comment by our readers on recent publications concerning the prevention of cardiovascular disease and we welcome letters to the editor.